Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
Jay Powell U.S. economy

The US economy is on a tear. Will it keep up?

The American economy is on a hot streak. We’ll have a better idea of just how hot it is — and whether that might be a problem — later this morning when the Commerce Department releases Q1 GDP data.

Economists surveyed by the Wall Street Journal are guessing the U.S. economy will have grown by an annual rate of 2.2% in Q1. That’d technically mark a slowdown from the last quarter of 2023 when GDP clocked in at 3.4%.

But it’s tough to know how much stock to hold in those estimates at this point, frankly. The growth of the U.S. economy has consistently blown past analyst expectations over the last two years. A widely-predicted recession has proven elusive despite historically high interest rates and growing instability abroad.

Policymakers at the Federal Reserve will take a hard look at these figures as they face an increasingly uncertain inflation landscape. Strong GDP growth is generally a good thing, but a hotter economy is harder to shake inflation out of.

Fed Chair Jay Powell said earlier this month that recent higher-than-hoped-for inflation data tied to the Consumer Price Index had “clearly not given us greater confidence” in having price increases under control.

This data dump will dovetail nicely with the Fed’s preferred gauge of inflation these days — the personal consumption expenditures index — when it’s released Friday morning. After that, all eyes will turn to the Federal Open Market Committee when Powell announces the Fed’s next interest rate move. Don’t expect a cut anytime soon.

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.